NCT01752894

DETErmination of the Duration of the Dual Antiplatelet Therapy by the Degree of the Coverage of The Struts on Optical Coherence Tomography From the Randomized Comparison Between Everolimus-eluting Stents(EES) Versus Biolimus A9-eluting Stents(BES)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 776 (actual)
• Sponsor: Yonsei University · Academic / Other
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is 1\> to compare neointimal stent coverage after OCT-guided vs. Angio-guided PCI, 2\> to compare neointimal stent coverage at 3 months after EES vs BES implantation, 3\> to determine the duration of dual antiplatelet therapy by OCT measurement at 3 months

Conditions

• Ischemic Heart Disease

Interventions

Type	Name	Description
DEVICE	Angio-guided PCI with EES or BES	Angio-guided intervention
DEVICE	OCT-guided PCI with EES or BES	OCT-guided intervention
DEVICE	PCI with BES under angio-guide or OCT guide	biolimus A9-eluting stent.
DEVICE	PCI with EES under angio-guide or OCT guide	everolimus eluting stent.
DRUG	Keep DAPT	maintain DAPT for 12 months according to level of uncovered strut (\>6%) at 3months OCT follow up after stent implantation.
DRUG	Discontinue DAPT	discontinue DAPT according to level of uncovered strut (≤6%) at 3months OCT follow up after stent implantation.

Timeline

• Start date: 2013-01-02
• Primary completion: 2017-04-11
• Completion: 2017-04-11
• First posted: 2012-12-19
• Last updated: 2019-03-21

Locations

1 site across 1 country: South Korea